Results for Nitric Oxide

1 - 9 of 9
Harry Ischiropoulos, PhD
Haralambos Ischiropoulos

Dr. Ischiropoulos's research objectives are to develop and test novel therapeutics for long-chain fatty acid oxidation (LCFA) disorders, a collection of inherited metabolic diseases that affect the heart, liver and muscle. A second area of interest is the resolution of the nitric oxide signaling pathways at the proteome level in the cardiovascular and neuronal systems.

E-mail:
ischirop [at] pennmedicine.upenn.edu
Stanley Stachelek, PhD
Stanley J. Stachelek

Dr. Stachelek's research interests are in the cellular and molecular mechanisms that control vasculature inflammation.

E-mail:
stachelek [at] chop.edu
Benjamin J. Samelson-Jones, MD, PhD
Benjamin J. Samelson-Jones

Dr. Samelson-Jones is a pediatric hematologist dedicated to improving the lives of children with bleeding and clotting disorders. His research focuses on gene therapy for hemophilia, the biochemical basis of coagulation, and the immune responses to hemophilia therapies.

E-mail:
samelsonjonesb [at] chop.edu
Eric C. Eichenwald, MD
Eric C. Eichenwald

Dr. Eichenwald's research interests include clinical trials and quality improvement in neonatal-perinatal medicine. He has extensive experience in the conduct of multicenter clinical trials, having served as a site principal investigator for several funded, multicenter randomized trials of interventions aimed at improving outcomes of premature newborns.

E-mail:
eichenwald [at] chop.edu
Robert Sutton MD, MSCE, FAAP, FCCM
Robert M. Sutton

Dr. Sutton is an internationally recognized expert in pediatric cardiac arrest. His career focus is on developing and evaluating novel techniques and devices to improve the care delivered during in-hospital resuscitation attempts.

E-mail:
suttonr [at] chop.edu

CHOP Researchers Highlight Advances in Pediatric Heart Disease at American College of Cardiology 67th Annual Scientific Session & Expo 2018

Published on
Mar 14, 2018
in Press Releases
Physician-researchers from the Cardiac Center at Children’s Hospital of Philadelphia (CHOP) presented new findings on pediatric cardiovascular disease at the American College of Cardiology’s 67th Annual Scientific Session & Expo 2018 in Orlando, Fla.

Intravenous Arginine Benefits Children after Acute Metabolic Strokes

Published on
Mar 9, 2018
in Press Releases
CHOP Researchers Find Notable Responses, No Adverse Events in Children with Mitochondrial Disease

Research Terminology Must Harmonize to Advance Science

Published on
Jun 9, 2014
in Cornerstone Blog
What one researcher describes as asthma, another might call reactive airway disease. Unfortunately, such examples demonstrate the lack of a common pediatric research terminology, which presents a barrier to data reuse, sharing, and integration.

Ischiropoulos Laboratory

Ischiropoulos Lab

The research objectives of the Ischiropoulos Lab are to elucidate the nitric oxide signaling pathways at the proteome level in the cardiovascular and neuronal systems; define the molecular mechanisms by which nitric oxide signaling regulates metabolic pathways during development and aging; and develop and test novel therapeutics for long-chain f

1 - 9 of 9